<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">321750</id>
  <title nil="true"/>
  <common-name>8-[(6-hydroxy-2,4-dioxo-1h-pyrimidin-5-yl)diazenyl]-7-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methylpurine-2,6-dione</common-name>
  <description>8-[(6-hydroxy-2,4-dioxo-1h-pyrimidin-5-yl)diazenyl]-7-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methylpurine-2,6-dione is a chemical compound with the formula C20H20N8O8. With an average molecular weight of 500.40 g/mol, 8-[(6-hydroxy-2,4-dioxo-1h-pyrimidin-5-yl)diazenyl]-7-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methylpurine-2,6-dione is a heavy molecule.</description>
  <cas>476481-74-0</cas>
  <pubchem-id>4308146</pubchem-id>
  <chemical-formula>C20H20N8O8</chemical-formula>
  <weight>500.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-29T21:24:30Z</created-at>
  <updated-at type="dateTime">2026-08-29T21:24:30Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN1C2=C(C(=O)NC1=O)N(C(=N2)N=NC3=C(NC(=O)NC3=O)O)CC(COC4=CC=C(C=C4)OC)O</moldb-smiles>
  <moldb-formula>C20H20N8O8</moldb-formula>
  <moldb-inchi>InChI=1S/C20H20N8O8/c1-27-14-13(17(32)24-20(27)34)28(7-9(29)8-36-11-5-3-10(35-2)4-6-11)18(21-14)26-25-12-15(30)22-19(33)23-16(12)31/h3-6,9,29H,7-8H2,1-2H3,(H,24,32,34)(H3,22,23,30,31,33)</moldb-inchi>
  <moldb-inchikey>GVAIIXIEGIFPRK-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">500.1404096</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-0.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM317643</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>8-[(6-hydroxy-2,4-dioxo-1h-pyrimidin-5-yl)diazenyl]-7-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methylpurine-2,6-dione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Imidazopyrimidines</klass>
  <subklass>Purines and purine derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0272467</sync-id>
  <structure-inchikey>GVAIIXIEGIFPRK-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000100000000000000800002000200800000000000000000000000100000000000004000000020200000800000002020002000080000000000000000000400000000000000080000000400002000000020200000000100000204000002020080040000210000010040000000000000000000001100000000008000000000000400800040000000000000200000004000000002000000000000080000000000000000000000000000000000080000000000000084080004000000000000000080000000200000002000200000000000400000008000000000004200000000000000000000000081000044000000000020000000000000000000080000000200</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMHQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:26:30Z</structure-indexed-at>
</compound>
